Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2003 Mar 15;111(6):925. doi: 10.1172/JCI200113419C

MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If

Barbara Schenk 1, Timo Imbach 1,2, Christian G Frank 1, Claudia E Grubenmann 2, Gerald V Raymond 3, Haggit Hurvitz 4, Annick Raas-Rotschild 5, Anthony S Luder 6, Jaak Jaeken 7, Eric G Berger 2, Gert Matthijs 8, Thierry Hennet 2, Markus Aebi 1, Jaak Jaeken 7
PMCID: PMC153781

Original citation: J. Clin. Invest. 108:1687–1695 (2003). doi:10.1172/JCI200113419.

Citation for this corrigendum: J. Clin. Invest. 111:925 (2003). doi:10.1172/JCI200113419C.

Barbara Schenk,1 Timo Imbach,2 Christian G. Frank,1 Claudia E. Grubenmann,2 Gerald V. Raymond,3 Haggit Hurvitz,4 Isabelle Korn-Lubetzki,4 Shoshana Revel-Vik,4 Annick Raas-Rotschild,5 Anthony S.Luder,6 Jaak Jaeken,7 Eric G. Berger,2 Gert Matthijs,8 Thierry Hennet,2 and Markus Aebi1

1Institute of Microbiology, Swiss Federal Institute of Technology, Zurich, Switzerland 2Institute of Physiology, University of Zurich, Switzerland 3Kennedy Krieger Institute, Baltimore, Maryland, USA 4Department of Pediatrics, Bikur Cholim Hospital, Jerusalem, Israel 5Genetic Clinic, Hadassah University Hospital, Jerusalem, Israel 6Department of Pediatrics, Sieff Hospital, Safed, Israel, and Faculty of Medicine, Technion, Haifa, Israel 7Department of Pediatrics, University Hospital, Leuven, Belgium 8Center for Human Genetics, Catholic University, Leuven, Belgium


Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES